Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
AstraZeneca
Maia Biotechnology
Bristol-Myers Squibb
Intergroupe Francophone de Cancerologie Thoracique
National Cancer Institute (NCI)
Hoffmann-La Roche
Qilu Pharmaceutical Co., Ltd.
Shanghai Chest Hospital
Betta Pharmaceuticals Co., Ltd.
Shanghai Pulmonary Hospital, Shanghai, China
University of Turin, Italy
CTI BioPharma
Canadian Cancer Trials Group
Alliance for Clinical Trials in Oncology
Xinqiao Hospital of Chongqing
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Merck KGaA, Darmstadt, Germany
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Spectrum Pharmaceuticals, Inc
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute (NCI)
QLT Inc.
The Norwegian Lung Cancer Study Group
Hellenic Oncology Research Group
Hellenic Oncology Research Group
Aktion Bronchialkarzinom e.V.
Inje University